KANORICHEM Latest Share Price (KANORICHEM)
TODAY IN ONE LINE
With a market cap of ₹729.9 Cr., it trades at a P/E of 4.98. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
KANORICHEM flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Reasonable ValuationTrading at a moderate P/E of 4.4x
- ●High Promoter HoldingPromoters hold 73.4% skin-in-the-game
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 3.3%
- ●Rising Receivables vs SalesReceivables grew 19.9% outpacing sales growth of 4.2%
Latest KANORICHEM News
What changed recently?
Recent events, corporate actions, and announcements.
KANORICHEM valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for KANORICHEM, framed against the sector median so the premium or discount is obvious at a glance.
KANORICHEM trades at a P/E of 4.98× and P/B of 1.35×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
KANORICHEM technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for KANORICHEM — derived from the latest tape, not yesterday's close.
KANORICHEM last traded at ₹92.22 with an intraday range of ₹90.85–₹99.45 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹92.22| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 114.70 | +22.48 | +24.37% |
| R3 | 106.10 | +13.88 | +15.05% |
| R2 | 102.77 | +10.55 | +11.44% |
| R1 | 97.50 | +5.28 | +5.72% |
| PIVOT | 94.17 | 1.95 | 2.12% |
| CURRENT | 92.22 | — | — |
| S1 | 88.90 | -3.32 | -3.60% |
| S2 | 85.57 | -6.65 | -7.21% |
| S3 | 80.30 | -11.92 | -12.93% |
| S4 | 71.70 | -20.52 | -22.25% |
KANORICHEM is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹–₹
Trading Below opening range, showing Bearishness
KANORICHEM financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for KANORICHEM — consolidated or standalone — with margins, YoY growth and key ratios inline.
KANORICHEM reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹729.9 Cr. and reported EPS of ₹6.25.
| Metric | Mar 2026 | May 2026 |
|---|---|---|
| Revenue from Operations | 981 | 981 ▲ 0.0% |
| Sales Growth YoY %Derived | -36.13% | — |
| Other Income | 22 | 22 ▲ 0.0% |
| Total Income | 1,004 | 1,004 ▲ 0.0% |
| 707 | 707 ▲ 0.0% | |
| Gross ProfitDerived | 274 | 274 ▲ 0.0% |
| Gross Margin %Derived | 27.94% | 27.94% |
| 203 | 203 ▲ 0.0% | |
| EBITDA (Operating Profit)Derived | 71 | 71 ▲ 0.0% |
| OPM %Derived | 7.27% | 7.27% |
| 67 | 67 ▲ 0.0% | |
| Profit Before Tax (PBT) | 27 | 27 ▲ 0.0% |
| -6 | -6 ▲ 0.0% | |
| Effective Tax %Derived | -21.55% | -21.55% |
| Profit/Loss from Discontinued Ops | 81 | 81 ▲ 0.0% |
| Total Profit for Period | 113 | 113 ▲ 0.0% |
| Less: Non-controlling Interests | -8 | -8 ▲ 0.0% |
| Net Profit (Owner's PAT)Derived | 121 | 121 ▲ 0.0% |
| Net Profit Margin %Derived | 12.31% | 12.31% |
| PAT Growth YoY %Derived | 244.47% | — |
| Earnings Per Share (EPS ₹) | 27.64 | 27.64 ▲ 0.0% |
| Diluted Shares Outstanding (Cr) | 4 | 4 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | 31 | 31 ▲ 0.0% |
| Total Expenses (incl. D&A & Interest) | 977 | 977 ▲ 0.0% |
| Material Cost % of RevenueDerived | 61.49% | 61.49% |
| Employee Cost % of RevenueDerived | 5.95% | 5.95% |
| Other Cost % of RevenueDerived | 14.72% | 14.72% |
| Interest Coverage (x)Derived | 1.13x | 1.13x |
| Period | Mar 2019 | Oct 2019 | Mar 2020 | Jun 2020 | Mar 2021 | May 2021 | Mar 2022 | May 2022 | Mar 2023 | May 2023 | Mar 2024 | May 2024 | Mar 2025 | Mar 2026 | May 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 1,074 | 1,074 ▲ 0.0% | 1,005 ▼ 6.4% | 1,005 ▲ 0.0% | 1,095 ▲ 9.0% | 1,095 ▲ 0.0% | 1,369 ▲ 25.0% | 1,369 ▲ 0.0% | 1,578 ▲ 15.3% | 1,578 ▲ 0.0% | 1,477 ▼ 6.4% | 1,477 ▲ 0.0% | 1,537 ▲ 4.1% | 981 ▼ 36.1% | 981 ▲ 0.0% | |
| Sales Growth YoY %Derived | — | — | -6.41% | — | 8.97% | — | 25.05% | 25.05% | 15.29% | 15.29% | -6.44% | -6.44% | 4.06% | -36.13% | — | |
| Other Income | 12 | 12 ▲ 0.0% | 22 ▲ 78.1% | 22 ▲ 0.0% | 12 ▼ 45.3% | 12 ▲ 0.0% | 29 ▲ 141.7% | 29 ▲ 0.0% | 10 ▼ 64.2% | 10 ▲ 0.0% | 19 ▲ 86.5% | 19 ▲ 0.0% | 9 ▼ 52.2% | 22 ▲ 143.8% | 22 ▲ 0.0% | |
| Total Income | 1,086 | 1,086 ▲ 0.0% | 1,027 ▼ 5.5% | 1,027 ▲ 0.0% | 1,107 ▲ 7.8% | 1,107 ▲ 0.0% | 1,398 ▲ 26.3% | 1,398 ▲ 0.0% | 1,589 ▲ 13.6% | 1,589 ▲ 0.0% | 1,496 ▼ 5.8% | 1,496 ▲ 0.0% | 1,546 ▲ 3.3% | 1,004 ▼ 35.1% | 1,004 ▲ 0.0% | |
725 | 725 ▲ 0.0% | 681 ▼ 6.1% | 681 ▲ 0.0% | 725 ▲ 6.6% | 725 ▲ 0.0% | 952 ▲ 31.2% | 952 ▲ 0.0% | 1,116 ▲ 17.2% | 1,116 ▲ 0.0% | 996 ▼ 10.8% | 996 ▲ 0.0% | 1,066 ▲ 7.0% | 707 ▼ 33.6% | 707 ▲ 0.0% | ||
| Gross ProfitDerived | 348 | 348 ▲ 0.0% | 324 ▼ 7.0% | 324 ▲ 0.0% | 369 ▲ 14.1% | 369 ▲ 0.0% | 417 ▲ 12.9% | 417 ▲ 0.0% | 462 ▲ 10.8% | 462 ▲ 0.0% | 481 ▲ 4.0% | 481 ▲ 0.0% | 471 ▼ 2.0% | 274 ▼ 41.8% | 274 ▲ 0.0% | |
| Gross Margin %Derived | 32.43% | 32.43% | 32.24% | 32.24% | 33.74% | 33.74% | 30.46% | 30.46% | 29.28% | 29.28% | 32.56% | 32.56% | 30.66% | 27.94% | 27.94% | |
284 | 284 ▲ 0.0% | 296 ▲ 4.0% | 296 ▲ 0.0% | 276 ▼ 6.7% | 276 ▲ 0.0% | 349 ▲ 26.5% | 349 ▲ 0.0% | 390 ▲ 11.7% | 390 ▲ 0.0% | 428 ▲ 9.8% | 428 ▲ 0.0% | 440 ▲ 2.7% | 203 ▼ 53.9% | 203 ▲ 0.0% | ||
| EBITDA (Operating Profit)Derived | 64 | 64 ▲ 0.0% | 28 ▼ 55.8% | 28 ▲ 0.0% | 94 ▲ 232.9% | 94 ▲ 0.0% | 68 ▼ 27.2% | 68 ▲ 0.0% | 72 ▲ 6.2% | 72 ▲ 0.0% | 53 ▼ 27.2% | 53 ▲ 0.0% | 31 ▼ 40.5% | 71 ▲ 127.4% | 71 ▲ 0.0% | |
| OPM %Derived | 5.93% | 5.93% | 2.80% | 2.80% | 8.55% | 8.55% | 4.98% | 4.98% | 4.58% | 4.58% | 3.57% | 3.57% | 2.04% | 7.27% | 7.27% | |
80 | 80 ▲ 0.0% | 93 ▲ 15.8% | 93 ▲ 0.0% | 87 ▼ 6.7% | 87 ▲ 0.0% | 84 ▼ 3.1% | 84 ▲ 0.0% | 95 ▲ 13.1% | 95 ▲ 0.0% | 103 ▲ 8.6% | 103 ▲ 0.0% | 79 ▼ 23.4% | 67 ▼ 14.9% | 67 ▲ 0.0% | ||
| Profit Before Tax (PBT) | -15 | -15 ▲ 0.0% | -43 ▼ 185.9% | -43 ▲ 0.0% | 11 ▲ 126.7% | 11 ▲ 0.0% | 13 ▲ 14.9% | 13 ▲ 0.0% | -12 ▼ 193.0% | -12 ▲ 0.0% | -36 ▼ 194.5% | -36 ▲ 0.0% | -97 ▼ 170.4% | 27 ▲ 127.4% | 27 ▲ 0.0% | |
5 | 5 ▲ 0.0% | -11 ▼ 349.6% | -11 ▲ 0.0% | -5 ▲ 59.6% | -5 ▲ 0.0% | 11 ▲ 339.0% | 11 ▲ 0.0% | 1 ▼ 93.9% | 1 ▲ 0.0% | 19 ▲ 2783.6% | 19 ▲ 0.0% | 12 ▼ 38.9% | -6 ▼ 148.6% | -6 ▲ 0.0% | ||
| Effective Tax %Derived | -30.17% | -30.17% | 26.34% | 26.34% | -39.90% | -39.90% | 83.02% | 83.02% | -5.49% | -5.49% | -53.73% | -53.73% | -12.13% | -21.55% | -21.55% | |
| Profit/Loss from Discontinued Ops | — | — | — | — | — | — | — | — | — | — | — | — | 1 | 81 ▲ 8880.0% | 81 ▲ 0.0% | |
| Total Profit for Period | -20 | -20 ▲ 0.0% | -32 ▼ 61.8% | -32 ▲ 0.0% | 16 ▲ 150.7% | 16 ▲ 0.0% | 2 ▼ 86.1% | 2 ▲ 0.0% | -13 ▼ 677.6% | -13 ▲ 0.0% | -55 ▼ 329.2% | -55 ▲ 0.0% | -108 ▼ 95.6% | 113 ▲ 204.7% | 113 ▲ 0.0% | |
| Less: Non-controlling Interests | -5 | -5 ▲ 0.0% | -6 ▼ 26.0% | -6 ▲ 0.0% | 1 ▲ 125.5% | 1 ▲ 0.0% | -5 ▼ 412.2% | -5 ▲ 0.0% | -4 ▲ 12.0% | -4 ▲ 0.0% | -17 ▼ 317.8% | -17 ▲ 0.0% | -25 ▼ 45.4% | -8 ▲ 69.1% | -8 ▲ 0.0% | |
| Net Profit (Owner's PAT)Derived | -15 | -15 ▲ 0.0% | -26 ▼ 72.7% | -26 ▲ 0.0% | 15 ▲ 156.3% | 15 ▲ 0.0% | 7 ▼ 53.0% | 7 ▲ 0.0% | -9 ▼ 229.6% | -9 ▲ 0.0% | -38 ▼ 334.4% | -38 ▲ 0.0% | -84 ▼ 117.7% | 121 ▲ 244.5% | 121 ▲ 0.0% | |
| Net Profit Margin %Derived | -1.39% | -1.39% | -2.57% | -2.57% | 1.33% | 1.33% | 0.50% | 0.50% | -0.56% | -0.56% | -2.60% | -2.60% | -5.44% | 12.31% | 12.31% | |
| PAT Growth YoY %Derived | — | — | -72.74% | — | 156.30% | — | -53.03% | -53.03% | -229.62% | -229.62% | -334.39% | -334.39% | -117.71% | 244.47% | — | |
| Earnings Per Share (EPS ₹) | -3.46 | -3.46 ▲ 0.0% | -5.90 ▼ 70.5% | -5.90 ▲ 0.0% | 3.47 ▲ 158.8% | 3.47 ▲ 0.0% | 1.58 ▼ 54.5% | 1.58 ▲ 0.0% | -2.02 ▼ 227.8% | -2.02 ▲ 0.0% | -8.79 ▼ 335.1% | -8.79 ▲ 0.0% | -19.13 ▼ 117.6% | 27.64 ▲ 244.5% | 27.64 ▲ 0.0% | |
| Diluted Shares Outstanding (Cr) | 4 | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | 4 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | -0 | -0 ▲ 0.0% | -1 ▼ 610.0% | -1 ▲ 0.0% | 1 ▲ 145.8% | 1 ▲ 0.0% | 0 ▼ 87.7% | 0 ▲ 0.0% | 18 ▲ 21862.5% | 18 ▲ 0.0% | 6 ▼ 65.5% | 6 ▲ 0.0% | 8 ▲ 33.3% | 31 ▲ 284.4% | 31 ▲ 0.0% | |
| Total Expenses (incl. D&A & Interest) | 1,101 | 1,101 ▲ 0.0% | 1,069 ▼ 2.9% | 1,069 ▲ 0.0% | 1,095 ▲ 2.4% | 1,095 ▲ 0.0% | 1,385 ▲ 26.4% | 1,385 ▲ 0.0% | 1,601 ▲ 15.6% | 1,601 ▲ 0.0% | 1,532 ▼ 4.3% | 1,532 ▲ 0.0% | 1,643 ▲ 7.3% | 977 ▼ 40.5% | 977 ▲ 0.0% | |
| Material Cost % of RevenueDerived | 68.75% | 68.75% | 68.86% | 68.86% | 64.91% | 64.91% | 71.57% | 71.57% | 72.45% | 72.45% | 66.96% | 66.96% | 68.30% | 61.49% | 61.49% | |
| Employee Cost % of RevenueDerived | 14.02% | 14.02% | 15.83% | 15.83% | 14.69% | 14.69% | 14.36% | 14.36% | 13.52% | 13.52% | 15.88% | 15.88% | 15.27% | 5.95% | 5.95% | |
| Other Cost % of RevenueDerived | 12.48% | 12.48% | 13.60% | 13.60% | 10.50% | 10.50% | 11.12% | 11.12% | 11.18% | 11.18% | 13.12% | 13.12% | 13.34% | 14.72% | 14.72% | |
| Interest Coverage (x)Derived | 0.39x | 0.39x | -0.76x | -0.76x | 1.10x | 1.10x | 0.41x | 0.41x | 0.37x | 0.37x | -0.23x | -0.23x | -0.68x | 1.13x | 1.13x |
KANORICHEM segment analysis : revenue and profit mix.
Disclosed business segments at KANORICHEM with their share of revenue and profit, switchable between consolidated and standalone reporting.
KANORICHEM discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for KANORICHEM.
Our AI distills the core fundamental drivers supporting KANORICHEM, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
KANORICHEM's investment case rests on 6 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Promoter holding is robust at 74.4%, indicating strong confidence from the core management in the company's long-term prospects and stability. This high stake aligns management interests with shareholder value.
The company's current price-to-book value is 0.66, significantly below its book value of 119.00. This suggests the stock might be undervalued relative to its assets, potentially offering an attractive entry point for investors.
Kanoria Chemicals reported a positive quarterly sales variation of 18.10%, with sales reaching 454 Cr. This indicates a recent uptick in revenue generation, which could be a sign of improving operational activity.
As part of the "Industrial Products" and "Capital Goods" sectors, the company could benefit from broader economic recovery or government infrastructure spending, driving demand for its offerings.
Given the current negative profitability and low stock valuation, any strategic improvements or favorable market shifts could lead to a significant turnaround and substantial upside for the stock.
Key Risks.
The company has reported significant negative profits, with a profit after tax of -49.4 Cr annually and -7.83 Cr in the last quarter. This indicates a severe lack of profitability and raises concerns about financial health.
Kanoria Chemicals exhibits poor return metrics, with ROCE at -2.33% and ROE at -11.80%. These negative figures highlight the company's inability to generate adequate returns from its capital and equity.
The debt-to-equity ratio stands at 1.14, indicating a substantial reliance on borrowed capital (595 Cr debt). This high leverage poses a significant financial risk and could strain future cash flows.
The current price of 78.90 is near its 52-week low of 73.00 and substantially below its 52-week high of 137.00, reflecting considerable investor apprehension and a downward trend in market valuation.
With an EPS of -17.1, the company is currently losing money per share, which is a major red flag for investors. This negative EPS directly contributes to the 0.00 P/E ratio, signaling unprofitability.
Flip Conditions.
Valuation risk. a P/E above 6 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.01. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
KANORICHEM peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — KANORICHEM is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
KANORICHEM chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for KANORICHEM — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
KANORICHEM delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for KANORICHEM over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in KANORICHEM stood at 62.6% of traded volume, against a 20-day average of 70.5%.
KANORICHEM announcements: results, concalls, ratings, M&A.
Filings KANORICHEM sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
KANORICHEM files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 67 documents below.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Compliance Certificate as per Regulation 74(5) of SEBI (Depositories & Participants) Regulation, 2018
Press Release
Kanoria Chemicals & Industries Limited has informed the Exchange regarding a press release dated October 07, 2026, titled "we are pleased to announce…
Credit Rating
Kanoria Chemicals & Industries Limited has informed the Exchange about Credit Rating
Trading Window
Kanoria Chemicals & Industries Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider…
Shareholders meeting
Kanoria Chemicals & Industries Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 02, 2026.…
Investor decks & rating reports.
KANORICHEM dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue KANORICHEM has declared, sequenced by announce and record date.
KANORICHEM corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About KANORICHEM: business, sector, key facts.
What KANORICHEM does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
KANORICHEM operates in the Industrial Products industry under the Capital Goods sector, listed as NSE: KANORICHEM, BSE: 506525.
Kanoria Chemicals & Industries Limited (KCIL) is an Indian chemical manufacturing and sales company with diverse operations. Its core business revolves around the production and distribution of chemical intermediates and specialty chemicals within the domestic Indian market and through exports. The company's product portfolio is extensive, encompassing a wide range of chemicals crucial to various industries. These include foundational chemicals such as acetaldehyde, formaldehyde, and pentaerythritol, as well as more specialized performance chemicals like phenolic resins. This broad product range caters to a diverse customer base across multiple sectors.
A significant portion of KCIL's business focuses on what it terms "Alco Chemicals," which encompasses the aforementioned chemical intermediates and specialties. The company leverages its expertise in chemical synthesis and processing to manufacture these products to meet the demands of various downstream industries. KCIL's commitment to quality control and its established distribution network contribute to its market position within India's competitive chemical landscape.
Beyond its core chemical operations, KCIL has diversified into other areas. A notable segment is its involvement in solar power generation. The company operates a 5 MW solar power plant situated in the Jodhpur district of Rajasthan, demonstrating a commitment to renewable energy sources and potentially reducing its carbon footprint. This diversification indicates a strategy to reduce reliance on single revenue streams and potentially open up new revenue opportunities in the growing renewable energy sector.
Further expanding its scope, KCIL also engages in the manufacturing and sale of yarn and denim fabrics. This venture suggests an interest in related textile industries, potentially leveraging existing supply chain relationships or targeting a synergistic customer base. Finally, KCIL designs and manufactures electronic and mechatronic modules and control devices for applications across diverse sectors, including automotive, consumer goods, power tools, and building automation. This area showcases the company's capacity to integrate technological advancements into its product offerings.
In summary, KCIL's business model is characterized by its diverse portfolio encompassing chemical manufacturing, solar power generation, textiles, and electronics. The company's long history, established presence in India, and strategic diversification efforts position it for continued growth and adaptation within a dynamic and evolving market.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- THE ANUP ENGINEERING (ANUP) Share PricePeer
- ATAM VALVES (ATAM) Share PricePeer
- INDEF MANUFACTURING (BAJAJINDEF) Share PricePeer
- CENTUM ELECTRONICS (CENTUM) Share PricePeer
- CYIENT DLM (CYIENTDLM) Share PricePeer
- Top Losers TodayScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about KANORICHEM (KANORICHEM).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of KANORICHEM (KANORICHEM)?
The current share price of KANORICHEM (KANORICHEM) is ₹92.22. Today, the stock has declined by ₹6.19 (6.29%), trading in a range of ₹90.85 to ₹99.45. The stock opened at ₹99.45 with a trading volume of 39,903 shares.
02Is KANORICHEM stock a good investment for long-term?
KANORICHEM can be considered for long-term investment based on several factors. The company has a market capitalization of ₹729.9 Cr., P/E ratio of 4.98, ROE of 3.34%, and ROCE of 5.74%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of KANORICHEM stock?
The 52-week high price of KANORICHEM (KANORICHEM) is ₹107.00, while the 52-week low is ₹56.00. Currently trading at ₹92.22, the stock is 64.68% above its 52-week low and 13.81% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy KANORICHEM stock at the current price?
Whether to buy KANORICHEM stock at ₹92.22 depends on multiple factors. The stock is currently trading with a P/E ratio of 4.98 and P/B ratio of 1.35. Today's performance shows a loss of 6.29%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of KANORICHEM and when is the next dividend?
KANORICHEM offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹92.22, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹5.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of KANORICHEM?
KANORICHEM's key financial metrics include: P/E Ratio: 4.98, P/B Ratio: 1.35, ROE: 3.34%, ROCE: 5.74%, Dividend Yield: 0%, EPS: ₹6.25, Book Value: ₹131.12, and Debt-to-Equity: 0.51. The company's market cap stands at ₹729.9 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is KANORICHEM stock performing today in the market?
KANORICHEM stock opened at ₹99.45 and is currently trading at ₹92.22, showing a decline of ₹6.19 (6.29%). The intraday high is ₹99.45 and low is ₹90.85. The trading volume stands at 39,903 shares, indicating moderate market participation today.
08What is the P/E ratio of KANORICHEM and what does it indicate?
KANORICHEM has a Price-to-Earnings (P/E) ratio of 4.98, which means investors are willing to pay 4.98 for every ₹1 of earnings. With an EPS of ₹6.25, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about KANORICHEM (KANORICHEM) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.